ON108110
CAS No. 1415599-79-9
ON108110( ON-108110 | ON 108110 )
Catalog No. M11727 CAS No. 1415599-79-9
ON108110 (ON-108110, ON 108110) is a novel multi-kinase inhibitor of protein kinase CK2 (CK2α1/2, IC50=3/2 nM) as well as CDK4/6 (IC50=2-24 nM).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameON108110
-
NoteResearch use only, not for human use.
-
Brief DescriptionON108110 (ON-108110, ON 108110) is a novel multi-kinase inhibitor of protein kinase CK2 (CK2α1/2, IC50=3/2 nM) as well as CDK4/6 (IC50=2-24 nM).
-
DescriptionON108110 (ON-108110, ON 108110) is a novel multi-kinase inhibitor of protein kinase CK2 (CK2α1/2, IC50=3/2 nM) as well as CDK4/6 (IC50=2-24 nM); reduces replication of influenza A virus in a dose-dependent manner by suppressing viral RNA synthesis, also inhibits other viruses including vesicular stomatitis virus and Newcastle disease virus; inhibits MCL and T-ALL cell growth (GI50 values of 0.2-3 uM), inhibits CK2 and CDK4/6 mediated oncogenic signaling.
-
In Vitro——
-
In Vivo——
-
SynonymsON-108110 | ON 108110
-
PathwayMetabolic Enzyme/Protease
-
TargetCasein Kinase
-
RecptorCasein Kinase
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1415599-79-9
-
Formula Weight374.342
-
Molecular FormulaC17H11FN2O5S
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES——
-
Chemical Name(Z)-4-((6-fluoro-3-oxo-3,4-dihydro-2H-benzo[b][1,4]thiazin-2-ylidene)methyl)-2-nitrophenyl acetate
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Padgaonkar A, et al. Oncotarget. 2018 Dec 28;9(102):37753-37765.
2. Martinez-Gil L, et al. Antiviral Res. 2013 Oct;100(1):29-37.
molnova catalog
related products
-
Quinalizarin
Quinalizarin is a potent, selective and cell-permeable inhibitor of CK2 with Ki of 58 nM.
-
TBBz
A potent, selective and ATP-competitive CK2 inhibitor with Ki of 0.5-1 uM; weakly inhibits CK1.
-
WAY-296817
WAY-296817 is casein kinase 1 (CK1) inhibitor and can be used for research on the treatment or prevention of diseases associated with circadiantiazol rhythm, inflammation diseases.
Cart
sales@molnova.com